Patent Assignment
Reel/Frame 049459/0299
Assignment of Assignor's Interest
Recorded: 2019-06-13
Pages: 3
Assignor
WEIDANZ, JON
Executed: 2019-05-20
Assignee
ABEXXA BIOLOGICS, INC.
NANOFAB BUILDING, BOX 19072, ARLINGTON, TEXAS, 76019
Covered Property
(1)
Combination Cancer Therapy with Anti-Cancer Agents and Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen
PCT:
PCT/US2019/019295 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Nov 15, 2019
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM VENTURE FUND USA, INC.
Reel/Frame 051016/0081 →
Merger
Jan 6, 2022
From: ABEXXA BIOLOGICS, INC.
To: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Reel/Frame 058584/0680 →
Assignment of Assignor's Interest
Nov 1, 2022
From: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 061615/0332 →